Arbutus Biopharma Corp (NASDAQ:ABUS)

Delayed Data
As of Sep 29
 +0.03 / +1.50%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Arbutus Biopharma Corp have a median target of 4.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +97.04% increase from the last price of 2.03.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Arbutus Biopharma Corp. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -16.00%
Growthannually 2.61%


Growthquarterly 32.39%
Growthannually -35.75%
Key to the earnings and sales forecast charts.